Clinical Research Organization: National / International - PA Based

Pennsylvania
listing image
Asking Price:$7,500,000
Established Year:1995
BUSINESS DESCRIPTION

Seller is retiring - Great Service and Reputation

This is an opportunity to acquire a reputable full-service Clinical Research Organization(CRO) for pharmaceuticals and for medical device programs, offering clinical, statistical and regulatory support from concept to market approval. The Company boasts a large number of returning clients, which ensures consistent demand and revenue year after year. Furthermore, their highly qualified staff of experts with a longstanding track record of excellence will provide a smooth transition for incoming ownership. The company is currently based in Pennsylvania. Their geographic footprint includes clients in the U.S., Canada, and Europe.

Tremendous untapped potential exists in the extensive pipeline of incoming business, licensing of its proprietary technology and the establishment of a new revenue stream of software and data licensing. Moreover, given that the Company’s current client acquisition strategy relies mostly on a word-of-mouth strategy, implementing marketing and sales campaigns, could lead to a seamless scaling of operations.

The current owners are seeking a full sale as they are nearing retirement and are searching for a new owner who will commit to scaling the business that they have established and led for over 25 years.

Financial information and confidential information memorandum (CIM) are available upon inquiry.


DETAILED INFORMATION
Location
Relocatable
Inventory
Not Included in asking price
Employees
28
Competition
The CRO market continues to grow and analytics to be provided upon inquiry
Growth & Expansion
- Geographic expansion: By using current collaborations buyer could expand market penetration and customer reach - Strengthen marketing efforts: Currently the business relies strongly upon word-of-mouth marketing and referrals for new client acquisition. - Software and data licensing: Potential untapped revenue stream from two proprietary technology solutions with trademark potential - Therapeutic expansion: New owner could leverage the diverse capabilities of the team currently in place to break into wider therapeutics markets diversifying clientele
Reason for Selling
Retirement
Report an Issue with this listing
profile-img
Isaac
Parker
logo-img
Isaac Parker